US Pharma MarketingThe investment comes from Dexcom, Google Ventures and Blue Cross Blue Shield of Alabama, with availability to purchase the device through Dexcom's Stelo website. Signos, maker of an over-the-counter glucose monitoring system for weight management, announced it secured $20 million in funding and a partnership with continuous glucose monitoring company Dexcom. Dexcom, GV (Google Ventures) and Blue Cross Blue Shield of Alabama participated in funding the round. Through the partnership with Dexcom, Signos will be available for purchase through Dexcom's direct-to-consumer continuous glucose monitoring website. Signos offers an FDA-cleared mobile app that uses an over-the-counter glucose monitor to provide insights…
Signos, maker of an over-the-counter glucose monitoring system for weight management, announced it secured $20 million in funding and a partnership with continuous glucose monitoring company Dexcom.
Dexcom, GV (Google Ventures) and Blue Cross Blue Shield of Alabama participated in funding the round.
Through the partnership with Dexcom, Signos will be available for purchase through Dexcom's direct-to-consumer continuous glucose monitoring website.
WHAT IT DOES
Source: MobiHealthNews